Relevance of circulating Semaphorin 4A for rheumatoid arthritis response to treatment

Abstract The lack of validated tools to predict rheumatoid arthritis (RA) disease course warrants the development of new reliable biomarkers. Our aim was to evaluate the merit of circulating SEMA4A for the prediction of outcomes in patients with RA. In a first cohort of 101 consecutive RA patients f...

Full description

Bibliographic Details
Published in:Scientific Reports
Main Authors: Jérôme Avouac, Eloïse Vandebeuque, Alice Combier, Lucile Poiroux, Alexia Steelandt, Margaux Boisson, Virginie Gonzalez, Anne Cauvet, Thomas Barnetche, Marie-Elise Truchetet, Christophe Richez, Yannick Allanore
Format: Article
Language:English
Published: Nature Portfolio 2023-09-01
Online Access:https://doi.org/10.1038/s41598-023-41943-3